Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5,434,244
-
Total 13F shares
-
8,902,107
-
Share change
-
-1,444,464
-
Total reported value
-
$45,255,770
-
Put/Call ratio
-
112%
-
Price per share
-
$5.10
-
Number of holders
-
65
-
Value change
-
-$6,915,082
-
Number of buys
-
32
-
Number of sells
-
26
Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q1 2021
As of 31 Mar 2021 Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,902,107 shares of stock of the company.
Largest 10 holders included Versant Venture Management, LLC, MORGAN STANLEY, BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, SG Americas Securities, LLC, 5AM Venture Management, LLC, Candriam Luxembourg S.C.A., TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 63 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.